Ca2+-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells

American Journal of Physiology

Volumn 281, Issue 6 PART 1, 2001, Pages

  Sanders, Jennifer L ^a   Chattopadhyay, Naibedya ^a   Kifor, Olga ^a   Yamaguchi, Toru ^a   Brown, Edward M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Ion sensing receptor; LnCaP cells; Osteolysis; Parathyroid hormone related protein; Prostate cancer; Skeletal metastases

Indexed keywords

EID: 33747320478     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Asadi F, Farraj M, Sharifi R, Malakouti S, Antar S, and Kukreja S. Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia. Hum Pathol 27: 1319-1323, 1996.
2. 2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99: 88-96, 1997.
3. o-sensing receptor. J Biol Chem 271: 19537-19545, 1996.
4. Boring CC, Squires TS, Tong T, and Montgomery S. Cancer statistics. CA Cancer J Clin 44: 7-26, 1994.
5. Brown EM, Bai M, and Pollak MR. Familial benign hypocalciuric hypercalcemia and other syndromes of altered responsiveness to extracellular calcium. In: Metabolic Bone Diseases and Clinically Related Disorders (3rd ed.), edited by S Krane and LV Avioli. San Diego, CA: Academic, 1997, p. 479-499.
6. (2+)-sensing receptor: a versatile regulator of diverse cellular functions. Vitam Horm 55: 1-71, 1999.
7. Burtis WJ, Wu T, Bunch C, Wysolmerski JJ, Insogna KL, Weir EC, Broadus AE, and Stewart AF. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem 262: 7151-7156, 1987.
8. (2+)-sensing receptor in rat intestine. Am J Physiol Gastrointest Liver Physiol 274: G122-G130, 1998.
9. Chattopadhyay N, Ye C, Singh DP, Kifor O, Vassilev PM, Shinohara T, Chylack, LT Jr, and Brown EM. Expression of extracellular calcium-sensing receptor by human lens epithelial cells. Biochem Biophys Res Commun 233: 801-805, 1997.
10. Coleman RE. Skeletal complications of malignancy. Cancer 80: 1588-1594, 1997.
11. Emanuel RL, Adler GK, Kifor O, Quinn SJ, Fuller F, Krapcho K, and Brown EM. Calcium-sensing receptor expression and regulation by extracellular calcium in the AtT-20 pituitary cell line. Mol Endocrinol 10: 555-565, 1996.
12. Freichel M, Zink-Lorenz A, Hollosehi A, Hafner M, Flockerzi V, and Raue F. Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion. Endocrinology 137: 3842-3848, 1996.
13. Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, Nemeth EF, and Fuller F. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270: 12919-12925, 1995.
14. Garrett JE, Tamir H, Kifor O, Simin RT, Rogers KV, Mithal A, Gagel RF, and Brown EM. Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 136: 5202-5211, 1995.
15. Gowen M, Stroup GB, Dodds RA, James IE, Votta BJ, Smith BR, Bhatnagar PK, Lago AM, Callahan JF, DelMar EG, Miller MA, Nemeth EF, and Fox J. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest 105: 1595-1604, 2000.
16. Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, Moseley JM, and Martin TJ. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 73: 1309-1315, 1991.
17. Grutters JC, Hermus ARMM, de Mulder PHM, and Bees LVAM. Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphonate (APD). Breast Cancer Res Treat 25: 277-281, 1993.
18. Guise TA and Mundy GR. Cancer and bone. Endocr Rev 19: 18-54, 1998.
19. Hansen MB, Nielsen SE, and Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203-210, 1989.
20. 2+-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 200: 295-302, 1997.
21. 2+ sensor and parathyroid hormone-related protein. Arch Biochem Biophys 307: 379-385, 1993.
22. Henderson J, Sebag M, Rhim J, Goltzman D, and Kremer R. Dysregulation of parathyroid hormone-like peptide expression and secretion in a keratinocyte model of tumor progression. Cancer Res 51: 6521-6528, 1991.
23. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, and Seidman CE. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11: 389-394, 1995.
24. Ikeda I, Miura T, and Kondo I. Pyridinium cross-links as urinary markers of bone metastases in patients with prostate cancer. Br J Urol 77: 102-106, 1996.
25. Iwamura M, di Sant'Agnese PA, Wu G, Benning CM, Cockett AT, Deftos LJ, and Abrahamsson PA. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res 53: 1724-1726, 1993.
26. Kifor O, Diaz R, Butters R, Kifor I, and Brown EM. The calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of bovine parathyroid cells. J Biol Chem 273: 21708-21713, 1998.
27. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81: 1598-1606, 1996.
28. Kremer R, Shustik C, Tabak T, Papavasiliou V, and Goltzman D. Parathyroid-hormone-related peptide in hematologic malignancies. Am J Med 100: 406-411, 1996.
29. Lin KI, Chattopadhyay N, Bai M, Alvarez R, Dang CV, Baraban JM, Brown EM, and Ratan RR. Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. Biochem Biophys Res Commun 249: 325-331, 1998.
30. McNeil SE, Hobson SA, Nipper V, and Rodland KD. Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium. J Biol Chem 273: 1114-1120, 1998.
31. Merryman JI, Capen CC, McCauley LK, Werkmeister JR, Suter MM, and Rosol TJ. Regulation of parathyroid hormone-related protein production by a squamous carcinoma cell line in vitro. Lab Invest 69: 347-354, 1993.
32. Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J, and Ashley S. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 11: 59-65, 1993.
33. Rabbani SA, Gladu J, Liu B, and Goltzman D. Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide. Endocrinology 136: 5416-5422, 1995.
34. Rizzoli R, Feyen JHM, Grau G, Wohlwend A, Sappino AP, and Bonjour JP. Regulation of parathyroid hormone-related protein production in a human lung squamous cell carcinoma line. J Endocrinol 143: 333-341, 1994.
35. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR, and Brown EM. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 141: 4357-4364, 2000.
36. Silver IA, Murrils RJ, and Etherington DJ. Microlectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175: 266-276, 1988.
37. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, and Nissenson RA. Parathyroid hormone-like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest 80: 1803-1807, 1987.
38. Sugihara A, Maeda O, Tsuji M, Tsujimura T, Nakata Y, Akedo H, Kotake T, and Terada N. Expression of cytokines enhancing the osteoclast activity, and parathyroid hormone-related protein in prostatic cancers before and after endocrine therapy: an immunohistochemical study. Oncol Res 5: 1389-1394, 1998.
39. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY, Hudson PJ, Martin TJ, and Wood WI. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237: 893-896, 1987.
40. Takeuchi S, Arai K, Saitoh H, Yoshida K, and Miura M. Urinary pyridinoline and deoxypyridinoline as potential markers of bone metastasis in patients with prostate cancer. J Urol 156: 1691-1695, 1996.
41. Van Holten-Verzantvoort AT, Bijvoet OL, Cleton FJ, Hermans J, Kroon HM, Harinck HI, Vermey P, Elte JW, Neijt JP, Beex LV, and Blijham G. Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet 2: 983-985, 1987.
42. Ward DT, Brown EM, and Harris HW. Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro. J Biol Chem 273: 14476-14483, 1998.
43. Yamaguchi T, Chattopadhyay N, Kifor O, Butters RR, Sugimoto T, Brown EM. Mouse osteoblastic cell line (MC3T3-E1) express extracellular calcium-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J Bone Miner Res 10: 1530-1538, 1998.
44. Yamaguchi T, Chattopadhyay N, Kifor O, Ye C, Vassilev PM, Sanders JL, and Brown EM. Expression of a functional extracellular calcium-sensing receptor (CaR) in the human osteoblastic MG-63 cell line. Am J Physiol Cell Physiol 280: C382-C393, 2001.